Tetrahydrocannabivarin (THCV) acts as a CB1 antagonist at low doses — the opposite move of THC — and early human studies explore it for appetite control and blood-sugar regulation. Effects flip at higher doses where it can activate CB1. Fascinating pharmacology, thin human data.